← Back to Search

Cross-Training Program for Cancer Survivors (CAPABLE Trial)

N/A

Recruiting

Led By Jennifer Beebe-Dimmer, MPH, PhD.

Research Sponsored by Barbara Ann Karmanos Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with an invasive cancer

Aged 18 years or older at time of program recruitment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

CAPABLE Trial Summary

This trial will see if cancer survivors who do a cross-training program improve more in functional performance, body composition, and quality of life compared to those who follow the American Cancer Society guidelines.

Who is the study for?

This trial is for cancer survivors who are 18 or older and have been diagnosed with invasive cancer. They must be cleared by their doctor to join the program, which could include those currently in treatment or those who've finished. Participants need a way to get to the facility on session days.Check my eligibility

What is being tested?

The study tests a 12-week cross-training program against current American Cancer Society guidelines for cancer survivors. It aims to see if this new approach can better improve functional performance, body composition, and quality of life.See study design

What are the potential side effects?

Since this is an exercise-based intervention rather than medication, side effects may include muscle soreness, fatigue, and potential injury from physical activity. The intensity will be tailored to each participant's ability.

CAPABLE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a cancer that is spreading into surrounding tissues.

Select...

I am 18 years old or older.

CAPABLE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Body Composition

Change in Motivation

Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program

+5 more

CAPABLE Trial Design

1Treatment groups

Experimental Treatment

Group I: A 12-week pilot intervention study introducing a high-intensiExperimental Treatment1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Barbara Ann Karmanos Cancer InstituteLead Sponsor

163 Previous Clinical Trials

9,156 Total Patients Enrolled

Jennifer Beebe-Dimmer, MPH, PhD.Principal Investigator - Barbara Ann Karmanos Cancer Institute

Barbara Ann Karmanos Cancer Institute

Media Library

12 week pilot intervention study Clinical Trial Eligibility Overview. Trial Name: NCT03750981 — N/A

Cancer Survivors Research Study Groups: A 12-week pilot intervention study introducing a high-intensi

Cancer Survivors Clinical Trial 2023: 12 week pilot intervention study Highlights & Side Effects. Trial Name: NCT03750981 — N/A

12 week pilot intervention study 2023 Treatment Timeline for Medical Study. Trial Name: NCT03750981 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant count of this clinical trial?

"Yes, the information available on clinicaltrials.gov reveals that enrollment is still open for this medical trial which was originally posted in November 2018 and modified as recently as April 2022. The researchers need to find 100 patients from a single site."

Answered by AI

Are there vacancies in this research project for participants?

"Per information available on clinicaltrials.gov, this medical experiment is presently open for recruitment of patients and has been active since its initial posting date of November 12th 2018. The trial was updated most recently on April 5th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

C.A.P.A.B.L.E. (Cross-Training and Physical Activity: A Better Life Experience Study)

Jennifer Beebe-Dimmer, PhD 2018. "C.A.P.A.B.L.E. (Cross-Training and Physical Activity: A Better Life Experience Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03750981.